← Eichor
Study identifier: NCT07725926 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)

Condition: Obsessive - Compulsive Disorder · Tic Disorder, Chronic Motor or Vocal · Tic Disorders  ·  Sponsor: University College London Hospitals

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Obsessive-Compulsive Disorder and Tic Disorders frequently co-occur, and a subgroup of patients - those with a Tourettic Subtype of OCD (TOCD) - present with concurrent obsessive-compulsive and tic symptoms. Existing psychological interventions typically target one condition or the other, but rarely both together. This study aims to test whether a combined psychological therapy integrating Exposure and Response Prevention (ERP) and Habit Reversal (HbRT) is more effective at reducing symptoms than either therapy delivered alone, in adults with TOCD.

This description comes directly from the study's public registry record.

Talk to the study team

Dipesh Patel, MPhil / PhD  ·  +44 (0)20 3456 7890  ·  dipesh.patel.23@ucl.ac.uk

Always discuss trial participation with your own doctor first.

Locations (2)

University College London Hospitals NHS Foundation TrustLondon, London, United KingdomRecruiting
University College London Queen Square Institute of NeurologyLondon, London, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07725926